Advanced Protein Technologies and Drug Development
Bridging the gap of technological advances in life sciences between China and the world
Product No.:
Synonyms:
Opdivo, ONO-4538,
BMS-936558, MDX1106
Target:
PD-1
Description:
Nivolumab,
sold under the brand name Opdivo, is a medication used to treat a number of
types of cancer. This includes melanoma, lung cancer, malignant pleural
mesothelioma, renal cell carcinoma, Hodgkin lymphoma, head and neck cancer,
urothelial carcinoma, colon cancer, esophageal squamous cell carcinoma, liver
cancer, gastric cancer, and esophageal or gastroesophageal junction (GEJ)
cancer. It is used by slow injection into a vein.
Source:
CHO
Purity:
Greater than 98% by SDS-PAGE gel and HPLC
analyses.
Bioactivity:
Copyright © 2021 Leto Laboratories Co.,Ltd.All rights
reserved。京ICP备2022031530号 copyright:Beijing Leto Laboratories
Biotechnology Co., Ltd 京公网安备
11011402011944号